Ocular adverse events associated with topical corticosteroid use in dermatology: A systematic review

被引：0
|
作者：
Ricardo, Jose W. [1 ]
Wang, Yu [2 ]
Haidari, Wasim [2 ]
Jorizzo, Joseph L. [2 ]
机构：
[1] Weill Cornell Med, Dept Dermatol, New York, NY USA
[2] Wake Forest Univ, Dept Dermatol, Winston Salem, NC 27101 USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2023年 / 88卷 / 04期
关键词：
cataract; dermatology; glaucoma; side effect; systematic review; topical corticosteroid;
D O I：
10.1016/j.jaad.2022.10.026
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
[No abstract available]
引用
收藏
页码：897 / 898
页数：2
相关论文
共 50 条
  • [1] Adverse events associated with home use of mouthrinses: a systematic review
    Tartaglia, Gianluca M.
    Tadakamadla, Santosh Kumar
    Connelly, Stephen Thaddeus
    Sforza, Chiarella
    Martin, Conchita
    THERAPEUTIC ADVANCES IN DRUG SAFETY, 2019, 10
  • [2] Incidence and US Costs of Corticosteroid-Associated Adverse Events: A Systematic Literature Review
    Sarnes, Evelyn
    Crofford, Leslie
    Watson, Maria
    Dennis, Greg
    Kan, Hong
    Bass, Damon
    CLINICAL THERAPEUTICS, 2011, 33 (10) : 1413 - 1432
  • [3] FLUOCINONIDE GLYCOGEL - TOPICAL CORTICOSTEROID SYSTEM FOR USE IN DERMATOLOGY
    LONGHI, A
    GIORNALE ITALIANO DI DERMATOLOGIA MINERVA DERMATOLOGICA, 1973, 108 (11): : 593 - 596
  • [4] Use of topical tretinoin and the development of noncutaneous adverse events: Evidence from a systematic review of the literature
    Shapiro, Stanley
    Heremans, Annie
    Mays, David A.
    Martin, Amber L.
    Hernandez-Medina, Marisol
    Lanes, Stephan
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2011, 65 (06) : 1194 - 1201
  • [5] Metabolic adverse events associated with systemic corticosteroid therapy-a systematic review and meta-analysis
    Kulkarni, Spoorthy
    Durham, Hannah
    Glover, Luke
    Ather, Osaid
    Phillips, Veronica
    Nemes, Szilard
    Cousens, Leslie
    Blomgran, Parmis
    Ambery, Philip
    BMJ OPEN, 2022, 12 (12):
  • [6] ADVERSE-EFFECTS OF TOPICAL CORTICOSTEROID USE
    FISHER, DA
    WESTERN JOURNAL OF MEDICINE, 1995, 162 (02): : 123 - 126
  • [7] Topical sirolimus in dermatology: a systematic review
    Afzal, Usamah M.
    Alazemi, Mohammad
    Ali, Omar
    Ali, Faisal R.
    Lear, John T.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2024,
  • [8] THE USE OF PHOSPHODIESTERASE 5 INHIBITORS IS NOT ASSOCIATED WITH OCULAR ADVERSE EVENTS
    Belladelli, Federico
    Li, Shufeng
    Zhang, Chiyuan A.
    Del Giudice, Francesco
    Glover, Frank
    Muncey, Wade
    Basran, Satvir
    Montorsi, Francesco
    Salonia, Andrea
    Eisenberg, Michael
    JOURNAL OF UROLOGY, 2023, 209 : E333 - E333
  • [9] Use of phosphodiesterase 5 inhibitors is not associated with ocular adverse events
    Belladelli, Federico
    Li, Shufeng
    Zhang, Chiyuan A.
    Muncey, Wade
    Del Giudice, Francesco
    Glover, Frank
    Seranio, Nicolas
    Basran, Satvir
    Fallara, Giuseppe
    Montorsi, Francesco
    Salonia, Andrea
    Eisenberg, Michael L.
    JOURNAL OF SEXUAL MEDICINE, 2023, 20 (12): : 1399 - 1406
  • [10] Injectable and topical neurotoxins in dermatology Indications, adverse events, and controversies
    Giordano, Cerrene N.
    Matarasso, Seth L.
    Ozog, David M.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : 1027 - 1044
12345